Literature DB >> 19892009

Investigation of reproductive toxicity of piperaquine in mice.

Kevin T Batty1, Brioni R Moore, Verity Stirling, Kenneth F Ilett, Madhu Page-Sharp, Keith B Shilkin, Ivo Mueller, Stephen J Rogerson, Harin A Karunajeewa, Timothy M E Davis.   

Abstract

Reproductive toxicity data for the antimalarial drug piperaquine (PQ) were obtained in pregnant mice (F(0)) and their offspring (F(1) and F(2)). PQ phosphate (0-300 mg/kg/day) was given to pregnant Swiss mice from gestational days 14-18. Two F(1) pups from each litter (one male and one female) proceeded to maturity and were mated within dose groups. Biochemical and haematological indices were determined, and liver and kidney histopathology was assessed in F(1) and F(2) mice at 4 weeks. There were no significant dose-related adverse effects, but leucocytes were mildly elevated (F(1) and F(2) mice) and serum albumin was reduced (F(1) only) in the 300 mg/kg/day group. Low plasma PQ concentrations were detected in F(1) mice at 4 and 8 weeks. Although we found no significant PQ toxicity, clinical data are lacking and monitoring of women and their infants for biochemical and haematological adverse effects is recommended when PQ is used in pregnancy. Copyright 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19892009     DOI: 10.1016/j.reprotox.2009.10.013

Source DB:  PubMed          Journal:  Reprod Toxicol        ISSN: 0890-6238            Impact factor:   3.143


  5 in total

1.  Population pharmacokinetics, tolerability, and safety of dihydroartemisinin-piperaquine and sulfadoxine-pyrimethamine-piperaquine in pregnant and nonpregnant Papua New Guinean women.

Authors:  John M Benjamin; Brioni R Moore; Sam Salman; Madhu Page-Sharp; Somoyang Tawat; Gumal Yadi; Lina Lorry; Peter M Siba; Kevin T Batty; Leanne J Robinson; Ivo Mueller; Timothy M E Davis
Journal:  Antimicrob Agents Chemother       Date:  2015-05-11       Impact factor: 5.191

2.  Safety, tolerability and pharmacokinetic properties of coadministered azithromycin and piperaquine in pregnant Papua New Guinean women.

Authors:  Brioni R Moore; John M Benjamin; Siu On Auyeung; Sam Salman; Gumul Yadi; Suzanne Griffin; Madhu Page-Sharp; Kevin T Batty; Peter M Siba; Ivo Mueller; Stephen J Rogerson; Timothy Me Davis
Journal:  Br J Clin Pharmacol       Date:  2016-03-27       Impact factor: 4.335

3.  Pharmacokinetics of piperaquine in pregnant women in Sudan with uncomplicated Plasmodium falciparum malaria.

Authors:  Ishag Adam; Joel Tarning; Niklas Lindegardh; Hyder Mahgoub; Rose McGready; François Nosten
Journal:  Am J Trop Med Hyg       Date:  2012-07       Impact factor: 2.345

4.  Reproductive and endocrine effects of artemisinin, piperaquine, and artemisinin-piperaquine combination in rats.

Authors:  Xiaobo Li; Yueming Yuan; Yingyi Chen; Li Ru; Zheng Yuan; Zhiyong Xu; Qin Xu; Jianping Song; Guoming Li; Changsheng Deng
Journal:  BMC Complement Med Ther       Date:  2022-10-13

5.  Dihydroartemisinin-piperaquine treatment of multidrug resistant falciparum and vivax malaria in pregnancy.

Authors:  Jeanne Rini Poespoprodjo; Wendy Fobia; Enny Kenangalem; Daniel A Lampah; Paulus Sugiarto; Emiliana Tjitra; Nicholas M Anstey; Ric N Price
Journal:  PLoS One       Date:  2014-01-17       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.